142 related articles for article (PubMed ID: 33151675)
1. Callyspongiolide Is a Potent Inhibitor of the Vacuolar ATPase.
Fogarty S; Ouyang Y; Li L; Chen YC; Rane H; Manoni F; Parra KJ; Rutter J; Harran PG
J Nat Prod; 2020 Nov; 83(11):3381-3386. PubMed ID: 33151675
[TBL] [Abstract][Full Text] [Related]
2. Identification of inhibitors of vacuolar proton-translocating ATPase pumps in yeast by high-throughput screening flow cytometry.
Johnson RM; Allen C; Melman SD; Waller A; Young SM; Sklar LA; Parra KJ
Anal Biochem; 2010 Mar; 398(2):203-11. PubMed ID: 20018164
[TBL] [Abstract][Full Text] [Related]
3. Iejimalides show anti-osteoclast activity via V-ATPase inhibition.
Kazami S; Muroi M; Kawatani M; Kubota T; Usui T; Kobayashi J; Osada H
Biosci Biotechnol Biochem; 2006 Jun; 70(6):1364-70. PubMed ID: 16794315
[TBL] [Abstract][Full Text] [Related]
4. Vacuolar and plasma membrane proton pumps collaborate to achieve cytosolic pH homeostasis in yeast.
Martínez-Muñoz GA; Kane P
J Biol Chem; 2008 Jul; 283(29):20309-19. PubMed ID: 18502746
[TBL] [Abstract][Full Text] [Related]
5. Concanamycin and indolyl pentadieneamide inhibitors of the vacuolar H+-ATPase bind with high affinity to the purified proteolipid subunit of the membrane domain.
Whyteside G; Meek PJ; Ball SK; Dixon N; Finbow ME; Kee TP; Findlay JB; Harrison MA
Biochemistry; 2005 Nov; 44(45):15024-31. PubMed ID: 16274249
[TBL] [Abstract][Full Text] [Related]
6. Interaction of inhibitors of the vacuolar H(+)-ATPase with the transmembrane Vo-sector.
Páli T; Whyteside G; Dixon N; Kee TP; Ball S; Harrison MA; Findlay JB; Finbow ME; Marsh D
Biochemistry; 2004 Sep; 43(38):12297-305. PubMed ID: 15379568
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide production by the vacuolar-type (H+)-ATPase inhibitors bafilomycin A1 and concanamycin A and its possible role in apoptosis in RAW 264.7 cells.
Hong J; Nakano Y; Yokomakura A; Ishihara K; Kim S; Kang YS; Ohuchi K
J Pharmacol Exp Ther; 2006 Nov; 319(2):672-81. PubMed ID: 16895977
[TBL] [Abstract][Full Text] [Related]
8. Identification of a new chondropsin class of antitumor compound that selectively inhibits V-ATPases.
Bowman EJ; Gustafson KR; Bowman BJ; Boyd MR
J Biol Chem; 2003 Nov; 278(45):44147-52. PubMed ID: 12944415
[TBL] [Abstract][Full Text] [Related]
9. Estimating the rotation rate in the vacuolar proton-ATPase in native yeast vacuolar membranes.
Ferencz C; Petrovszki P; Kóta Z; Fodor-Ayaydin E; Haracska L; Bóta A; Varga Z; Dér A; Marsh D; Páli T
Eur Biophys J; 2013 Mar; 42(2-3):147-58. PubMed ID: 23160754
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of V-ATPase inhibition by bafilomycin A1.
Wang R; Wang J; Hassan A; Lee CH; Xie XS; Li X
Nat Commun; 2021 Mar; 12(1):1782. PubMed ID: 33741963
[TBL] [Abstract][Full Text] [Related]
11. V-ATPase (Vacuolar ATPase) Activity Required for ABCA1 (ATP-Binding Cassette Protein A1)-Mediated Cholesterol Efflux.
Lorkowski SW; Brubaker G; Gulshan K; Smith JD
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2615-2625. PubMed ID: 30354238
[TBL] [Abstract][Full Text] [Related]
12. Diphyllin, a novel and naturally potent V-ATPase inhibitor, abrogates acidification of the osteoclastic resorption lacunae and bone resorption.
Sørensen MG; Henriksen K; Neutzsky-Wulff AV; Dziegiel MH; Karsdal MA
J Bone Miner Res; 2007 Oct; 22(10):1640-8. PubMed ID: 17576165
[TBL] [Abstract][Full Text] [Related]
13. The dual mechanism of the antifungal effect of new lysosomotropic agents on the Saccharomyces cerevisiae RXII strain.
Krasowska A; Chmielewska L; Łuczyński J; Witek S; Sigler K
Cell Mol Biol Lett; 2003; 8(1):111-20. PubMed ID: 12655364
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of V-ATPase proton transport reveal uncoupling functions of tether linking cytosolic and membrane domains of V0 subunit a (Vph1p).
Chan CY; Prudom C; Raines SM; Charkhzarrin S; Melman SD; De Haro LP; Allen C; Lee SA; Sklar LA; Parra KJ
J Biol Chem; 2012 Mar; 287(13):10236-10250. PubMed ID: 22215674
[TBL] [Abstract][Full Text] [Related]
15. The vacuolar-ATPase inhibitor bafilomycin and mutant VPS35 inhibit canonical Wnt signaling.
George A; Leahy H; Zhou J; Morin PJ
Neurobiol Dis; 2007 Apr; 26(1):125-33. PubMed ID: 17239604
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the yeast KEX2 gene cause a Vma(-)-like phenotype: a possible role for the Kex2 endoprotease in vacuolar acidification.
Oluwatosin YE; Kane PM
Mol Cell Biol; 1998 Mar; 18(3):1534-43. PubMed ID: 9488470
[TBL] [Abstract][Full Text] [Related]
17. EPR Studies of V-ATPase with Spin-Labeled Inhibitors DCC and Archazolid: Interaction Dynamics with Proton Translocating Subunit c.
Gölz JP; Bockelmann S; Mayer K; Steinhoff HJ; Wieczorek H; Huss M; Klare JP; Menche D
ChemMedChem; 2016 Feb; 11(4):420-8. PubMed ID: 26662886
[TBL] [Abstract][Full Text] [Related]
18. A vacuolar-type H+-ATPase and a Na+/H+ exchanger contribute to intracellular pH regulation in cockroach salivary ducts.
Hille C; Walz B
J Exp Biol; 2007 Apr; 210(Pt 8):1463-71. PubMed ID: 17401129
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of the V-ATPase inhibitors concanamycin and indole pentadiene in lipid membranes. Spin-label EPR studies.
Páli T; Dixon N; Kee TP; Marsh D
Biochim Biophys Acta; 2004 May; 1663(1-2):14-8. PubMed ID: 15157605
[TBL] [Abstract][Full Text] [Related]
20. A plant proton-pumping inorganic pyrophosphatase functionally complements the vacuolar ATPase transport activity and confers bafilomycin resistance in yeast.
Pérez-Castiñeira JR; Hernández A; Drake R; Serrano A
Biochem J; 2011 Jul; 437(2):269-78. PubMed ID: 21612578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
